Orforglipron, which could be approved for obesity next quarter, proved superior at cutting blood sugar and body weight — but ...
Feb 26 (Reuters) - Eli Lilly's experimental weight-loss pill, orforglipron, caused more side effects and treatment ...
Feb 25 (Reuters) - Danish drugmaker Novo Nordisk has partnered with U.S.-based Vivtex Corp in a deal worth up to $2.1 billion ...
The potentially $2.1 billion collaboration gives Novo access to technologies that are meant to help optimize the delivery of ...
Resident Evil’s Umbrella Corporation has filed a fictional copyright infringement lawsuit against Nissin Foods, the Japanese ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results